![Jamie Dananberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jamie Dananberg
Chief Tech/Sci/R&D Officer at
ANNEXON, INC.
Net worth: 669 814 $ as of 2026-05-30
Profile
Jamie Dananberg is currently Chief Medical Officer & Executive Vice President at Annexon, Inc. since 2023 and serves as a Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include VP-Translational Medicine & Tailored Therapeutics at Eli Lilly & Co. from 2000 to 2012, Executive Vice President at Takeda Pharmaceutical Co., Ltd. from 2012 to 2015, and Chief Medical Officer at Unity Biotechnology, Inc. from 2016 to 2023.
Education includes undergraduate and doctorate degrees from Tufts University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANNEXON, INC. 0.08% | 2026-03-01 | 123,582 ( 0.08% ) | 669 814 $ | 2026-05-30 |
Jamie Dananberg active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXON, INC. | Chief Tech/Sci/R&D Officer | 2023-07-26 |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
Former positions of Jamie Dananberg
| Companies | Position | End |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2023-04-29 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2015-09-30 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2012-08-31 |
Training of Jamie Dananberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
- Stock Market
- Insiders
- Jamie Dananberg
